Browsing: leads

Press Trust of IndiaAmaravati2 min read Last Updated : Aug 16 2026 | 11:26 PM IST

Global interest rates have become harder to read as central banks react to sticky inflation and higher energy costs. That uncertainty keeps pressure on weaker balance sheets. Founder-led companies with high capital efficiency and real skin in the game can stand out when money is more selective. This article highlights 3 stocks from the Top…

AI related investment is helping lift growth expectations across parts of the Eurozone, even as inflation and rates stay in focus. That mix keeps attention on companies powering the ChatGPT and AI build out, from chips to cloud to software. Investors who ignore this may miss some of the clearest capital spending trends in markets…

Global investors are watching central banks closely as mixed inflation readings in the US shape expectations for interest rate stability. That keeps borrowing costs and discount rates in focus, which matters for fast growing areas like artificial intelligence. When money is not getting more expensive as quickly, attention often shifts back to growth stories. This…

Dubai, United Arab Emirates: Autodesk has released new regional findings from its 2026 State of Design & Make: AI Pulse report, revealing that Middle East organisations are leading globally in translating AI investment into measurable business outcomes. 

River AI, an AI startup founded by xAI co-founder Igor Babuschkin, has secured $1.1 billion in funding in a seed/Series A round led by General Catalyst and AMP PBC, with participation from Nvidia, AMD Ventures, Y Combinator, and Temasek. 

Add to Google Preferred Sources Corma, a Tel Aviv and San Francisco-based startup, has raised $60 million in seed funding led by Sequoia Capital to build a foundation model specifically for defensive cybersecurity. The company argues that general-purpose AI models are highly capable as attackers but poor as defenders, citing internal simulations where AI attackers…

Lifespan Vision Ventures is leading a planned $10 million Series A financing for Remedium Bio, completing the round’s initial closing with participation from Eli Lilly and Company and HKX Capital as the biotechnology company advances its durable protein therapeutics platform toward human clinical development.

Investment supports advancement of Remedium’s durable protein therapeutics platform toward first-in-human clinical development.

CHONGQING, China – Zhang Xue wept with joy and furiously waved a Chinese flag as he watched his company’s superbike scream across the finish line four seconds ahead of competitors in only its third world championship race.